Inciardi, Riccardo
 Distribuzione geografica
Continente #
NA - Nord America 1.571
EU - Europa 527
AS - Asia 473
OC - Oceania 5
SA - Sud America 4
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.583
Nazione #
US - Stati Uniti d'America 1.559
SG - Singapore 183
HK - Hong Kong 139
DE - Germania 105
IT - Italia 101
FI - Finlandia 91
IE - Irlanda 76
TR - Turchia 69
CN - Cina 64
GB - Regno Unito 43
UA - Ucraina 40
CZ - Repubblica Ceca 19
FR - Francia 16
SE - Svezia 14
CA - Canada 12
IN - India 11
BE - Belgio 9
AU - Australia 5
CL - Cile 3
NL - Olanda 3
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
ES - Italia 1
EU - Europa 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
IR - Iran 1
KZ - Kazakistan 1
MU - Mauritius 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
TN - Tunisia 1
Totale 2.583
Città #
Fairfield 196
Ashburn 152
Singapore 145
Hong Kong 138
Chandler 127
Princeton 126
Woodbridge 95
New York 90
Helsinki 86
Houston 81
Wilmington 80
Seattle 75
Cambridge 72
Dublin 70
Istanbul 64
Jacksonville 46
Ann Arbor 39
San Diego 24
Brescia 23
Munich 23
Shanghai 21
Des Moines 20
Beijing 19
Brno 19
London 19
Milan 13
Romola 12
Frankfurt am Main 11
Washington 10
Brussels 9
San Francisco 8
Toronto 8
Los Angeles 7
Menlo Park 6
Pune 6
Rome 6
Verona 6
Padova 5
Gunzenhausen 4
Kilburn 4
Strasbourg 4
Changsha 3
Chiswick 3
Espoo 3
Haikou 3
Islington 3
Leipzig 3
Melbourne 3
Norwalk 3
Paris 3
Acton 2
Bedizzole 2
Canberra 2
Chennai 2
Falkenstein 2
Hanover 2
Kocaeli 2
Lappeenranta 2
Montreal 2
Nanjing 2
Naples 2
New Bedfont 2
Skopje 2
Tianjin 2
Agropoli 1
Almaty 1
Atlanta 1
Baku 1
Barrow 1
Bologna 1
Bussolengo 1
Castegnato 1
Chicago 1
Chongqing 1
Eindhoven 1
Enschede 1
Esslingen am Neckar 1
Guangzhou 1
Hangzhou 1
Hebei 1
Jakarta 1
Jiaxing 1
Jinan 1
Kashan 1
Montichiari 1
Nanchang 1
Ningbo 1
North Bergen 1
Oklahoma City 1
Ottawa 1
Pedrengo 1
Perugia 1
Pontecagnano 1
Portland 1
Prescot 1
Ravenna 1
Redmond 1
Redwood City 1
Reggio Calabria 1
Riyadh 1
Totale 2.060
Nome #
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 133
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 122
Coronavirus 2019 Disease (COVID-19), Systemic Inflammation, and Cardiovascular Disease 84
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy 79
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world 63
Implications for the Care of Patients with COVID-19 and Inflammatory Myocardial Disease-Reply 60
Diagnosing pneumothorax through standardized bilateral ultrasound images comparison 60
COVID 19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease 57
Early Small Creatinine Shift Predicts Contrast-Induced Acute Kidney Injury and Persistent Renal Damage after Percutaneous Coronary Procedures: Early creatinine shift predicts CI-AKI 57
Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry 54
Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study 54
ACE2 down-regulation may contribute to the increased thrombotic risk in COVID-19 54
Atrial fibrillation in the COVID-19 era: Simple bystander or marker of increased risk? 49
Standardizing Bilateral Ultrasound Images Comparison for the Diagnosis of Pneumothorax: A Pilot Study 49
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features 46
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) 43
Prognostic effects of rosuvastatin in patients with co-existing chronic obstructive pulmonary disease and chronic heart failure: A sub-analysis of GISSI-HF trial 42
Atrial Fibrillation and Ischemic Stroke with the Amyloidogenic V122I Transthyretin Variant among Black Americans 39
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 38
Mitral regurgitation, left atrial structural and functional remodelling and the effect on pulmonary haemodynamics 38
Usefulness of strain imaging echocardiography in arrhythmogenic right ventricular cardiomyopathy: clinical perspective 38
Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study) 38
Echocardiographic advances in hypertrophic cardiomyopathy: Three-dimensional and strain imaging echocardiography 36
Cardiac Mechanics Assessment and the Risk of Heart Failure in the General Population 36
Mitral regurgitation, edge-to-edge valve repair and the left atrium: one step beyond the left ventricle? 35
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation 34
Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta-blockers in patients hospitalized for acute heart failure 34
Therapeutic management in Sicilian patients with definite arrhythmogenic right ventricular dysplasia/cardiomyopathy and focus on the role of implantable cardioverter-defibrillator therapy 34
Right cardiac chambers' involvement as the first manifestation of recurrent complex karyotype acute myeloid leukemia 33
Left atrial structure and function and the risk of death or heart failure in atrial fibrillation 32
Fill in the Gaps of Secondary Mitral Regurgitation: a Continuum Challenge From Pathophysiology to Prognosis 32
Vericiguat for Heart Failure with Reduced Ejection Fraction 32
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study 32
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study 31
Congestion in Patients with Advanced Heart Failure: Assessment and Treatment 31
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 31
Mitral regurgitation and dyspnoea: the expanding role of mitral effective regurgitant orifice among un-selected patients 31
Chemotherapy cardiotoxicity: Cardioprotective drugs and early identification of cardiac dysfunction 31
How to incorporate left atrial strain in the diagnostic algorithm of left ventricular diastolic dysfunction 31
Association of Echocardiographic Measures of Left Atrial Function and Size With Incident Dementia 30
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 28
Impact of COVID-2019 outbreak on prevalence, clinical presentation and outcomes of ST-elevation myocardial infarction 28
Treatment decision making in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: State of the art 28
Cardiovascular imaging in arrhythmogenic right ventricular dysplasia/cardiomyopathy 28
Anatomical features and clinical correlations in Caucasian patients with definite arrhythmogenic right ventricular dysplasia/cardiomyopathy 28
Cardiac Structure and Function and Diabetes‐Related Risk of Death or Heart Failure in Older Adults 28
Endothelial dysfunction in COVID-19 patients assessed with Endo-PAT2000 27
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 27
Prognostic Value of Minimal Left Atrial Volume in Heart Failure With Preserved Ejection Fraction 27
Left Atrial Structure and Function of the Amyloidogenic V122I Transthyretin Variant in Elderly African Americans 26
Long COVID-19: A Tangled Web of Lungs, Heart, Mind, and Gender 26
The prognostic value of serial troponin measurements in patients admitted for COVID-19 26
Cardiac biomarkers and mortality in COVID-19 infection: A review 25
Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure 25
Prognostic significance of serum potassium in patients hospitalized for acute heart failure 24
Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry 23
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study 22
Combined pre- and post-capillary pulmonary hypertension in left heart disease 22
Left atrial structural and mechanical remodelling in heart failure with reduced ejection fraction 22
Left atrium: A forgotten biomarker and a potential target in cardiovascular medicine 22
Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC Study 22
Association of Left Atrial Structure and Function With Heart Failure in Older Adults 22
Determinants of exercise intolerance symptoms considered non-specific for heart failure in patients with stage A and B: role of the left atrium in the transition phase to overt heart failure 21
Epicardial adipose tissue in heart failure: risk factor or mediator? 20
Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure 18
Implantation of a biventricular defibrillator in a borderline case of arrhythmogenic right ventricular dysplasia/cardiomyopathy 18
Association of Physical Activity With Left Atrial Function in Older Adults: The ARIC Study 17
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 17
Collagen homeostasis of the left atrium: an emerging treatment target to prevent heart failure? 16
Criteria for Iron Deficiency in Patients With Heart Failure 15
Left atrial disease and left atrial reverse remodelling across different stages of heart failure development and progression: a new target for prevention and treatment 14
Multimodality imaging in the diagnostic management of concomitant aortic stenosis and transthyretin-related wild-type cardiac amyloidosis 13
Prognostic Benefit of New Drugs for HFrEF: A Systematic Review and Network Meta-Analysis 13
Left Atrial Mechanical Dysfunction and the Risk for Ischemic Stroke in People Without Prevalent Atrial Fibrillation or Stroke : A Prospective Cohort Study 12
Identification and quantification of congestion in heart failure: a work in progress 12
Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction 10
Type of hospitalisations and in-hospital outcomes in the Italian coronary care unit network at the time of COVID-19 pandemic: the BLITZ-COVID19 Registry 10
Reply to "Clinical implications of left atrial changes after optimization of medical therapy in heart failure patients" 9
Totale 2.674
Categoria #
all - tutte 30.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.607


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202065 0 0 0 0 6 9 8 10 9 12 4 7
2020/2021572 8 13 8 48 7 14 230 56 52 50 70 16
2021/2022498 51 32 17 17 38 21 22 26 51 48 42 133
2022/2023475 81 33 11 13 24 126 1 39 77 1 38 31
2023/2024663 29 6 68 52 45 137 26 17 158 8 12 105
2024/2025327 12 22 20 187 86 0 0 0 0 0 0 0
Totale 2.674